section name header

Pronunciation

LAK-tyoo-lose

Classifications

Therapeutic Classification: laxatives

Pharmacologic Classification: osmotics

Indications

REMS


Action

  • Increases water content and softens the stool.
  • Lowers the pH of the colon, which inhibits the diffusion of ammonia from the colon into the blood, thereby reducing blood ammonia levels.
Therapeutic effects:
  • Relief of constipation.
  • Decreased blood ammonia levels with improved mental status in portal-systemic encephalopathy.

Pharmacokinetics

Absorption: Less than 3% absorbed after oral administration.

Distribution: Unknown.

Metabolism/Excretion: Absorbed lactulose is excreted unchanged in the urine. Unabsorbed lactulose is metabolized by colonic bacteria to lactic, acetic, and formic acids.

Half-Life: Unknown.

Time/Action Profile

(relief of constipation)

ROUTEONSETPEAKDURATION
PO24–48 hrunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Endo: hyperglycemia (patients with diabetes)

GI: belching, cramps, distention, flatulence, diarrhea

Interactions

Drug-drug:

Route/Dosage

Constipation

Portal-Systemic Encephalopathy

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Constulose, Enulose, Generlac, Kristalose

Code

NDC Code